Thursday, 4 December 2025

My Portfolio Nov25

 Summary For November 2025













Portfolio @ End of Nov25













November was a bad month to me as my portfolio was down by 5.3%, deepening the YTD loss to 8.9%.

The faint hope to end 2025 with a positive gain has officially gone.

The main culprit for the poor portfolio performance in Nov25 was MMSV, which plunged 41% after a poorer than expected FY25Q3 result.

Initially I didn't hold a lot of MMSV shares but I added more at 60sen before the result announcement.

It was not an extremely bad quarter result actually with net profit of RM1.85mil (EPS 0.94sen) but the market expected it to beat preceding FY25Q2 net profit of RM2.8mil.

Furthermore, the management painted a "challenging" future quarters which was exactly the opposite of what was said 3 months ago.

Together with major correction in tech sector globally, MMSV could not escape the heavy sell down.

I sold part of its shares at 55sen though, only to regret not selling all of them.


As soon as MI released its FY25Q3 result, I regretted disposing all its shares last month.

It was a record high revenue (RM197mil) & PATAMI (RM35.9mil, EPS 4.04sen) by a huge margin, without any significant one-off item.

Due to the "tech rout", MI's share price did not advance but instead dropped.

I thought it was a good opportunity to reinvest in it at least for short term, so I bought a bit at RM3.10, only to see it dropping further.

Anyway, I didn't commit a lot and I think it might resume its uptrend when the sentiment in tech sector turns positive.




JHM's share price quietly moved up 30% before its FY25Q3 result release. It seemed like a better quarter result was in the cards.

True enough, its FY25Q3 result was great, with revenue RM82.6mil & PATAMI RM4.8mil (EPS 0.79sen) improving both YoY & QoQ, recovering from a deep loss in preceding quarter.

I always have a plan to average down on my JHM investment but I hope to wait for a clearer sign. Now it looks like the time might have come.

There are many inventories held at its US warehouse and in transit via sea shipment. Will they turn into revenue in next quarter?

The RM300mil contract from Proton through its 52% owned subsidiary might be for the new Proton Saga which received superb response since being launched a week ago.

The management expects its financial performance to continue improving in the coming quarters. Hopefully it's not another MMSV.




















TMCLife also posted a better FY25Q3 result with record high revenue at RM100.5mil, and PATAMI of RM4.4mil (EPS 0.25sen).

This is the best quarter result since its former CEO was suspended back in FY24Q1.

When can it achieve RM10mil net profit per quarter again?


The latest quarter result of MFCB & KFIMA were good, but FocusP was a bit disappointing. 

FocusP has its best ever Q3 revenue at RM74.5mil but net profit dropped 22% YoY to RM6.3mil (EPS 1.02sen).

The drop in profit was mainly due to the loss in F&B segment, while its optical segment registered steady growth.

The latest interim dividend of 1.5sen is actually higher than the previous 1.75sen given before the bonus issue.


Now we are in the final month of year 2025.

There is a higher chance that the US Fed might cut the interest rate again in December, which should be positive to the stock market.

I just hope the stock market will end 2025 on a high note.


No comments:

Post a Comment